Case 2: Faricimab in treatment naïve neovascular nAMD patient
Video
Drs Khanani and Khoramnia review the case of a newly diagnosed nAMD patient who showed a rapid response in disease control after starting faricimab therapy.
Sponsored by Roche
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
